
|Videos|May 7, 2015
How Biosimilar Drug Approvals Provide Opportunities for Pharmacists
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
Advertisement
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
2
Current Pneumococcal Vaccination Recommendations: A Clinical Update
3
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
4
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
5

























